Quality Management Optimizing HEDIS & STARSAnthem Blue Cross and Blue Shield | CommercialFebruary 10, 2025

Colorectal Cancer Screening (COL-E) 2025

HEDIS® is a widely used set of performance measures developed by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.

The HEDIS quality measures reported using the electronic clinical data systems (ECDS) inspire innovative use of electronic clinical data to document high-quality patient care, demonstrating commitment to evidence-based practices. Organizations that report HEDIS using ECDS encourage the electronic exchange of the information needed to provide high-quality services, ensuring that the information reaches the right people at the right time.

HEDIS measure

This measure assesses the percentage of patients on a Medicare Advantage plan ages 45 to 75 who had an appropriate screening for colorectal cancer.

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-075487-24-CPN74910

ATTACHMENTS: Colorectal Cancer Screening (COL-E) 2025 (pdf - 0.12mb)